Skip to main content
. Author manuscript; available in PMC: 2022 Dec 20.
Published in final edited form as: Chem Res Toxicol. 2021 Nov 24;34(12):2579–2591. doi: 10.1021/acs.chemrestox.1c00347

Figure 8.

Figure 8.

EET analogues 1-4 do not affect the cytotoxicity of cisplatin (CDDP) towards HepG2 liver cancer cells. (A) Pre-treatment with analogues 1-4 (1 μM) or compound 5 (1 μM) did not exert protective effects in HepG2 cells exposed to CDDP (20 μM) for 24 h. (B) Compounds 1-5 (1 μM) had no significant influence on viability of HepG2 cells.